featured
Long-Term Outcomes and Genomic Correlates of Response After Neoadjuvant Chemotherapy ± Carboplatin and Bevacizumab in TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
J. Clin. Oncol 2022 Jan 19;[EPub Ahead of Print], JH Shepherd, K Ballman, MC Polley, JD Campbell, C Fan, S Selitsky, A Fernandez-Martinez, JS Parker, KA Hoadley, Z Hu, Y Li, MG Soloway, PA Spears, B Singh, SM Tolaney, G Somlo, ER Port, C Ma, C Kuzma, E Mamounas, M Golshan, JR Bellon, D Collyar, OM Hahn, CA Hudis, EP Winer, A Partridge, T Hyslop, LA Carey, CM Perou, WM SikovFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.